Sebastien Benzekry

Sebastien Benzekry is a scientific researcher (PhD, HDR) at Inria, the french institute for applied mathematics, computer science and their applications. He has created (in 2021) and heads the Inria – Inserm (French national institute for biomedical research) project-team COMPO (COMPutational pharmacology and clinical Oncology), affiliated to both Inria and the Center for Research on Cancer of Marseille (Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes Institute, Aix-Marseille University, Faculty of Pharmacy). The objective of his research is to model data arising from (clinical) oncology in order to 1) bring clinical decision tools to enhance therapeutic management, 2) better inform and design clinical trials and 3) test biological hypotheses. To do so, he combines mechanistic (i.e., simulation models of the pharmaco-patho-physiological processes in cancer) and statistical learning through an approach termed 'mechanistic learning'. He has fifteen years of experience in trans-disciplinary projects in oncology, with a strong track record of publications in high impact journals (Cancer Res, PLoS Comp Biol, Clin Pharmacol Ther,...). His main topics of research are modeling metastatic development and immuno-oncology, integrating longitudinal data. These are implemented into code libraries developed with a focus on software development standards. Dr Benzekry has an initial training in applied mathematics (Ecole Normale Supérieure) followed by a PhD at Aix-Marseille University and further training in computational / systems biology as a postdoc in the Center for Cancer and Systems Biology, Tufts Univ, Boston, MA. Citations: 2095, h-index 24 (11/2011 – 03/2024), 50 research articles, 24 book chapters, editorials and proceedings. https://team.inria.fr/compo/ https://www-sop.inria.fr/members/Sebastien.Benzekry/index.html https://scholar.google.fr/citations?user=xsLpdFAAAAAJ&hl=fr&oi=ao